.Nature Medicine, Posted online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medicine conjugate (ADC) tisotumab vedotin led to enhanced progression-free and also general survival, triggering FDA approval and also a brand new therapy choice for individuals.